Accent Microcell Ltd (ACCENTMIC) is currently trading at 331.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Accent Microcell Limited specializes in manufacturing cellulose-based excipients primarily used in pharmaceuticals, nutraceuticals, food, and cosmetics. Their core products include Microcrystalline Cellulose (MCC), Spray Dried MCC, and Silicified Microcrystalline Cellulose (SMCC). The company has a robust export footprint, contributing to over 53% of its revenue, indicating a strong presence in international markets. It has embarked on a strategic expansion to scale production and diversify product offerings. Accent is expanding its production capacity by establishing a third manufacturing facility with the ability to produce premium excipients like CCS, SSG, and CMC. Expected commercial operations are targeted by mid-2025. The company has sustained financial growth with revenues topping ₹265 crore in FY 2025 and an expected increase in profitability through higher-margin products. Accent has maintained a strong financial foundation with decreased borrowings and strategic plans to utilize internal accruals for its expansion, reflecting solid financial and operational management.

Over the past 52 weeks, Accent Microcell Ltd has traded between a low of ₹170.26 and a high of ₹378.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Accent Microcell Ltd has a market capitalization of approximately 829.18. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Accent Microcell Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.13 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 829.18 Cr, Accent Microcell Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Accent Microcell Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Accent Microcell Ltd is 21.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.